Almac Group unveils Almac One solution for clinical trial supply chain
Category: #health  By Mateen Dalal  Date: 2019-03-08
  • share
  • Twitter
  • Facebook
  • LinkedIn

Almac Group unveils Almac One solution for clinical trial supply chain

Almac One™ would help sponsors to face the challenges existing in the drug development market

It provide a single set of process to sponsors and enable greater visibility and control of supply chain

Reports confirm that Almac Group has recently introduced Almac One™, the first unified Clinical Trial Solution, for redefining the experience of a clinical supply chain and create an end-to-end responsive process which would enhance the accuracy and visibility across the clinical study lifecycle.

The company has stated that the drug development market is continuously evolving with common challenges faced, like limited inventory, expensive investigational products as well as globalization of clinical trials. Supposedly, a key difficulty which sponsors are facing today is the disconnect existing throughout the clinical supply chain owing to variable recruitment patterns and demand from patients, leading to costly and disjointed trials with frequently missed targets.

According to an Almac Group press release, the company has leveraged more than thirty years of experience in Clinical Supplies delivery and services, along with Interactive Response Technology for developing Almac One™. It also aimed to fulfil the need for more smart, informed and timely decision making for aligning vital study data.

Almac mentioned that the Almac One™ solution brings together expert consultants from across the clinical logistics, packaging and IRT spectrum to offer a single set of process to sponsors, in combination with close-loop technology for managing data end-to-end which enables greater visibility and control in a supply chain across a study’s lifecycle. This is achieved by the alignment of patient recruitment, clinical IRT and supply strategies for delivering a seamless flow of data. 

Managing Director and President of Almac Clinical Technologies, Val Higgins said that Almac One™ would offer sponsors a more streamlined approach towards global supply chain and will empower clients to make faster, more accurate decisions for managing their studies. He added that the company’s latest development is a part of its ongoing program of solutions targeted at helping clients face the challenges which clinical supply chain may bring in the future.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Air France-KLM & JAL make bids to purchase stake in Malaysia Airlines
Air France-KLM & JAL make bids to purchase stake in Malaysia Airlines
By Mateen Dalal

Air France–KLM S.A., one of the leading global air transport players, has reportedly made a proposal to invest in Malaysia Airlines and gain around 49 percent stake. Japan Airlines (JAL) is also looking to acquire a 25 percent stake in Mal...

Accenture opens innovation center in South Beach Road office
Accenture opens innovation center in South Beach Road office
By Mateen Dalal

Accenture, an Irish multinational professional services company, has recently opened a global innovation center within the Accenture’s office at South Beach Road, which is supported by EDB (Economic Development Board) in Singapore. It will pro...

Verrica unveils positive data from VP-102 study in molluscum treatment
Verrica unveils positive data from VP-102 study in molluscum treatment
By Mateen Dalal

Findings from the study are being produced at the 17th Annual Winter Clinical Dermatology Conference in Kohala Coast The data indicated a considerable increase in the percentage of patients with lesion clearance in VP-102 group Verrica Pharmaceu...